People · Operator

JOHN E. VIOLA

Named in public records as an officer, director or promoter · active 2010–2015 · Other Health Care, Pharmaceuticals

2
Companies
4
Filings
$34.2M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
ASC Acquisition LLCOther Health CareSeries B$27.0M$16.5M2010
TPG Valley, L.P.PharmaceuticalsSeries A$7.3M$224.5M2015
Operator network

JOHN E. VIOLA at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

G Douglas Pucket · 1 companies · 1 sharedG Douglas PucketJeff E Ekberg · 1 companies · 1 sharedJeff E EkbergRonald G Cami · 1 companies · 1 sharedRonald G CamiSteven A Willman · 1 companies · 1 sharedSteven A WillmanTodd E Sisitsky · 1 companies · 1 sharedTodd E SisitskyTPG GenPar V, A L.P. · 1 companies · 1 sharedTPG GenPar V, A L…TPG Partners V, A L.P. · 1 companies · 1 sharedTPG Partners V, A…DAVID BONDERMAN · 5 companies · 2 sharedDAVID BONDERMANJAMES G. COULTER · 4 companies · 2 sharedJAMES G. COULTERSTEVEN A. WILLMANN · 4 companies · 2 sharedSTEVEN A. WILLMANNCLIVE BODE · 4 companies · 1 sharedCLIVE BODEMARTIN A. DAVIDSON · 2 companies · 1 sharedMARTIN A. DAVIDSONDAVID C. REINTJES · 1 companies · 1 sharedDAVID C. REINTJESASC Acquisition LLC · $27.0M raisedASC Acquisition LLCTPG Valley, L.P. · $7.3M raisedTPG Valley, L.P.JOHN E. VIOLAJV
JOHN E. VIOLA Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside JOHN E. VIOLA on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
DAVID BONDERMAN25
JAMES G. COULTER24
STEVEN A. WILLMANN24
CLIVE BODE14
MARTIN A. DAVIDSON12
Steven A Willman11
TPG Partners V, A L.P.11
Todd E Sisitsky11
Jeff E Ekberg11
DAVID C. REINTJES11
G Douglas Pucket11
TPG GenPar V, A L.P.11
Ronald G Cami11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.